Invitae Corporation (NYSE:NVTA) acquired PatientCrossroads, Inc. from Deborah H. Jae and Albert Carrasco for $15 million on January 6, 2017. Under the terms of agreement, Invitae will issue its shares of $5 million within 10 days after closing and will issue its shares of $10 million after closing based on revenue achieved and milestone achieved by PatientCrossroads, Inc. PatientCrossroads will now operate as a wholly owned subsidiary of Invitae. The transaction is not subject to approval by any applicable governmental entity or the approval of the stockholders of Invitae. Mike Hird of Pillsbury Winthrop Shaw Pittman LLP acted as legal advisor for Invitae. Kenyon Mark Lee of Lee Law Office acted as legal advisor for PatientCrossroads. Invitae Corporation (NYSE:NVTA) completed the acquisition of PatientCrossroads, Inc. from Deborah H. Jae and Albert Carrasco on January 6, 2017. Of the consideration, 5 million shares were issued on January 6, 2017.